Basic info
Industry
pharmaceutical manufacturing
Sectors
Fibrotic Cancer
Cancer
Claudin-1
Drug Discovery
Rare Diseases
Nephrology
Oncology
Kidney Fibrosis
Pulmonology
Claudin
Hepatology
Therapeutics
CLDN1
Kidney Disease
Drug Development
Lung Fibrosis
Liver Fibrosis
ALE.C04
ALE.F02
Date founded
2019
Funding rounds raised
Total raised
$105M
from 15 investors over 15 rounds
A
Alentis Therapeutics raised undisclosed on April 28, 2023
Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung
A
Alentis Therapeutics raised $105M on April 13, 2023
Investors: Pureos Bioventures, Schroders Capital, Novo Holdings, RA Capital Management, L.P. and JEITO
A
Alentis Therapeutics raised $67M on June 15, 2021
Investors: Pureos Bioventures, Kinled Holding Ltd, BioMedPartners, High-Tech Gründerfonds, Morningside Venture Capital 晨兴资本 and JEITO
A
Alentis Therapeutics raised $12M on April 29, 2019
Investors: Pureos Bioventures, High-Tech Gründerfonds and BioMedPartners